Australia  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

It's Who Puts Money in Cannabis Companies That Matters: Jim Cramer

Video Credit: The Street - Duration: 01:13s - Published < > Embed
It's Who Puts Money in Cannabis Companies That Matters: Jim Cramer

It's Who Puts Money in Cannabis Companies That Matters: Jim Cramer

Jim Cramer says that, while Real Money Stock of the Day Aurora Cannabis bringing on Nelson Peltz as an adviser is the right move, typically it's who puts money into the cannabis company that matters.

Although, Aurora's appointment of Peltz certainly doesn't hurt.

Peltz will advise the group on its global acquisition strategy and potential business partnership, Aurora Cannabis said.

"Nelson is a globally recognized business visionary with a strong track record of constructive engagement to generate accelerated, profitable growth and shareholder value across many industry verticals that are of great interest to us," said CEO Terry Booth.

"Like us, Nelson also takes a long-term view of value creation to benefit all stakeholders.

We look forward to working with Nelson to further extend our global cannabis industry leadership by aligning Aurora with each of the major market segments cannabis is set to impact." Related.

Aurora Cannabis Stock Burns Higher After Adding Billionaire Advisor Peltz Will I Have Enough Money to Retire?

Want to learn about retirement planning from some of the nation's top experts?

Join TheStreet's Robert "Mr. Retirement" Powell live in New York on April 6 for our Retirement Strategies Symposium.

For a limited time, tickets are available for $99 for this full-day event.

Check out the agenda, learn about the speakers and sign up here.

0
shares
ShareTweetSavePostSend
 

You Might Like


Recent related videos from verified sources

Jim Cramer's Thoughts on Biogen's Alzheimer's Drug [Video]Jim Cramer's Thoughts on Biogen's Alzheimer's Drug

Shares of Biogen were up close to 40% this morning after the company said it plans to pursue regulatory approval for aducanumab, a drug for early Alzheimer's disease. The stock has come down a bit..

Credit: The Street     Duration: 00:48Published

Jim Cramer Tackles McDonald's Earnings, WeWork and Softbank and Beyond Meat [Video]Jim Cramer Tackles McDonald's Earnings, WeWork and Softbank and Beyond Meat

Let's talk earnings. Jim Cramer is weighing in on Real Money Stock of the Day Mcdonald's Earnings, Beyond Meat and WeWork's ongoing headlines. McDonald's Earnings McDonald's reported adjusted..

Credit: The Street     Duration: 11:23Published

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.